BR0212522A - Ligando de ligação de zinco, hexâmero de insulina, preparação aquosa de insulina e métodos de prolongar a ação de uma preparação de insulina e de preparar um ligando de ligação de zinco - Google Patents
Ligando de ligação de zinco, hexâmero de insulina, preparação aquosa de insulina e métodos de prolongar a ação de uma preparação de insulina e de preparar um ligando de ligação de zincoInfo
- Publication number
- BR0212522A BR0212522A BR0212522-6A BR0212522A BR0212522A BR 0212522 A BR0212522 A BR 0212522A BR 0212522 A BR0212522 A BR 0212522A BR 0212522 A BR0212522 A BR 0212522A
- Authority
- BR
- Brazil
- Prior art keywords
- insulin
- binding ligand
- zinc binding
- action
- insulin preparation
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 16
- 102000004877 Insulin Human genes 0.000 title abstract 8
- 108090001061 Insulin Proteins 0.000 title abstract 8
- 229940125396 insulin Drugs 0.000 title abstract 8
- 238000002360 preparation method Methods 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 108010088577 zinc-binding protein Proteins 0.000 title 2
- 239000011701 zinc Substances 0.000 abstract 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052725 zinc Inorganic materials 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
"LIGANDO DE LIGAçãO DE ZINCO, HEXâMERO DE INSULINA, PREPARAçãO AQUOSA DE INSULINA E MéTODOS DE PROLONGAR A AçãO DE UMA PREPARAçãO DE INSULINA E DE PREPARAR UM LIGANDO DE LIGAçãO DE ZINCO". Novos ligandos para os sítios HISB10 Zn^ 2+^ do hexâmero de insulina de estado R que são capazes de prolongar a ação das preparações de insulina são divulgados.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101337 | 2001-09-14 | ||
US32392501P | 2001-09-21 | 2001-09-21 | |
DKPA200201066 | 2002-07-05 | ||
US39605102P | 2002-07-10 | 2002-07-10 | |
PCT/DK2002/000595 WO2003027081A2 (en) | 2001-09-14 | 2002-09-13 | NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0212522A true BR0212522A (pt) | 2004-08-10 |
Family
ID=27439845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0212522-6A BR0212522A (pt) | 2001-09-14 | 2002-09-13 | Ligando de ligação de zinco, hexâmero de insulina, preparação aquosa de insulina e métodos de prolongar a ação de uma preparação de insulina e de preparar um ligando de ligação de zinco |
Country Status (15)
Country | Link |
---|---|
US (1) | US7879893B2 (pt) |
EP (1) | EP1429763B1 (pt) |
JP (1) | JP4554207B2 (pt) |
CN (1) | CN1558762A (pt) |
AT (1) | ATE363278T1 (pt) |
BR (1) | BR0212522A (pt) |
CA (1) | CA2460541A1 (pt) |
CZ (1) | CZ2004313A3 (pt) |
DE (1) | DE60220424T2 (pt) |
ES (1) | ES2288195T3 (pt) |
HU (1) | HUP0401492A3 (pt) |
MX (1) | MXPA04002404A (pt) |
NO (1) | NO20041494L (pt) |
PL (1) | PL369119A1 (pt) |
WO (1) | WO2003027081A2 (pt) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070060606A1 (en) * | 1999-10-07 | 2007-03-15 | Robertson Harold A | Compounds and methods for modulating phosphodiesterase 10A |
US7087631B2 (en) * | 2002-07-18 | 2006-08-08 | Inotek Pharmaceuticals Corporation | Aryltetrazole compounds, and compositions thereof |
US7078423B2 (en) * | 2002-07-18 | 2006-07-18 | Inotek Pharmaceuticals Corporation | 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
US20040063098A1 (en) * | 2002-09-26 | 2004-04-01 | Hargreaves John S. | Methods for producing multilayer ligand arrays |
WO2004043955A1 (en) * | 2002-11-13 | 2004-05-27 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives and pharmaceutical compositions containing them |
US20050065066A1 (en) * | 2002-12-20 | 2005-03-24 | Kaarsholm Niels Christian | Stabilised insulin compositions |
DE60317565T2 (de) * | 2002-12-20 | 2008-09-11 | Novo Nordisk A/S | Pharmazeutische zusammensetzungen mit insulin und insulin-hexamer-liganden |
US7521465B2 (en) | 2003-01-17 | 2009-04-21 | Bexel Pharmaceuticals, Inc. | Diphenyl ether derivatives |
US7781464B2 (en) | 2003-01-17 | 2010-08-24 | Bexel Pharmaceuticals, Inc. | Heterocyclic diphenyl ethers |
WO2004080480A1 (en) * | 2003-03-11 | 2004-09-23 | Novo Nordisk A/S | Pharmaceutical preparations comprising acid-stabilised insulin |
US20060258561A1 (en) * | 2003-03-13 | 2006-11-16 | Novo Nordisk A/S | Novel NPH insulin preparations |
BRPI0411691A (pt) * | 2003-07-02 | 2006-12-26 | Teva Gyogyszergyar Reszvenytar | l-lisina de aztreonam e seus métodos de preparação |
US7087576B2 (en) * | 2003-10-07 | 2006-08-08 | Bexel Pharmaceuticals, Inc. | Dipeptide phenyl ethers |
US7037927B2 (en) * | 2003-10-16 | 2006-05-02 | Abbott Laboratories | Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
ES2369895T3 (es) | 2003-12-03 | 2011-12-07 | Novo Nordisk A/S | Insulina monocatenaria. |
EP2261218B1 (en) | 2004-05-26 | 2013-04-03 | Eisai R&D Management Co., Ltd. | Imidazole compound for use as an intermediate in the production of cinnamide compounds |
RU2006144821A (ru) * | 2004-07-08 | 2008-08-20 | Ново Нордиск А/С (DK) | Пролонгирующие метки полипептидов, содержащие тетразольную группировку |
WO2006005683A1 (en) * | 2004-07-09 | 2006-01-19 | Novo Nordisk A/S | Phamaceutical preparations comprising insulin |
BRPI0514133A (pt) * | 2004-08-05 | 2008-05-27 | Hoffmann La Roche | compostos de fórmula i, processo para a sua fabricação, composições farmacêuticas, método para o tratamento e/ou profilaxia de doença que são mediadas por inibidores de cetp e uso dos compostos de fórmula i |
JP2008513384A (ja) * | 2004-09-17 | 2008-05-01 | ノボ ノルディスク アクティーゼルスカブ | インスリンおよびインスリン分泌性ペプチドを含有する医薬組成物 |
CA2580811C (en) * | 2004-09-28 | 2014-04-08 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril compound |
ATE458729T1 (de) | 2004-10-26 | 2010-03-15 | Eisai R&D Man Co Ltd | Amorphe form einer zimtsäureamidverbindung |
TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
TW200800978A (en) * | 2006-03-23 | 2008-01-01 | Otsuka Pharma Co Ltd | Carbazole compound |
JP5191155B2 (ja) * | 2006-03-27 | 2013-04-24 | 大塚製薬株式会社 | カルボスチリル化合物からなる医薬 |
CL2008000582A1 (es) | 2007-02-28 | 2008-06-27 | Eisai R&D Man Co Ltd | Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis. |
US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
NZ583515A (en) | 2007-08-31 | 2011-05-27 | Eisai R&D Man Co Ltd | Imidazole-pyridine derivative featuring a 1,2,4-triazole ring fused to a 5-7 membered ring, for treating a disease caused by amyloid-beta such as Alzheimer's, dementia, Down's syndrome, and amyloidosis |
WO2013124245A1 (de) | 2012-02-21 | 2013-08-29 | Bayer Intellectual Property Gmbh | Herbizid wirksame 4-nitro substituierte n-(tetrazol-5-yl)-, n-(triazol-5-yl)- und n-(1,3,4-oxadiazol-2-yl)arylcarbonsäureamide |
EP2844260A4 (en) * | 2012-04-30 | 2016-06-29 | Anderson Gaweco | ROR MODULATORS AND ITS USES |
KR101942752B1 (ko) * | 2012-11-05 | 2019-01-28 | 주식회사 엘지화학 | Gpr120 효능제로서의 티오아릴 유도체 |
JP6156845B2 (ja) * | 2014-03-04 | 2017-07-05 | 株式会社島津製作所 | マトリックス支援レーザ脱離イオン化質量分析用マトリックス |
EP3230279A1 (en) * | 2014-12-10 | 2017-10-18 | Massachusetts Institute of Technology | Fused 1,3-azole derivatives useful for the treatment of proliferative diseases |
AR102981A1 (es) | 2014-12-11 | 2017-04-05 | Harvard College | Inhibidores de la necrosis celular y métodos de preparación de los mismos |
US10501413B2 (en) | 2015-03-23 | 2019-12-10 | University Of Miami | Inhibitors of the Notch transcriptional activation complex and methods for use of the same |
CA3012846A1 (en) | 2016-02-16 | 2017-08-24 | Massachusetts Institute Of Technology | Max binders as myc modulators and uses thereof |
EP3475264A4 (en) * | 2016-06-28 | 2020-04-15 | University Of Kentucky Research Foundation | PROSTAGLANDIN E-SYNTHASE INHIBITORS AND METHOD FOR USE THEREOF |
WO2018110669A1 (en) | 2016-12-15 | 2018-06-21 | Ono Pharmaceutical Co., Ltd. | Activator of trek (twik related k+ channels) channels |
AU2019236215B2 (en) * | 2018-03-16 | 2024-07-25 | The Board Of Regents Of The University Of Oklahoma | Agonists of peroxisome proliferator-activated receptor alpha and methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DOP1982004086A (es) | 1981-08-27 | 1988-03-22 | Lilly Co Eli | Formula farmaceutica que comprende insulina humana y proinsulina humana |
US5646120A (en) * | 1990-10-24 | 1997-07-08 | Allelix Biopharmaceuticals, Inc. | Peptide-based inhibitors of HIV replication |
US5830999A (en) | 1995-01-26 | 1998-11-03 | Regents Of The University Of California | Stabilization of insulin through ligand binding interations |
EP1131089B1 (en) * | 1998-11-18 | 2004-02-18 | Novo Nordisk A/S | Stable aqueous insulin preparations without phenol and cresol |
-
2002
- 2002-09-13 PL PL02369119A patent/PL369119A1/xx not_active Application Discontinuation
- 2002-09-13 MX MXPA04002404A patent/MXPA04002404A/es not_active Application Discontinuation
- 2002-09-13 DE DE60220424T patent/DE60220424T2/de not_active Expired - Lifetime
- 2002-09-13 CZ CZ2004313A patent/CZ2004313A3/cs unknown
- 2002-09-13 US US10/332,541 patent/US7879893B2/en not_active Expired - Fee Related
- 2002-09-13 BR BR0212522-6A patent/BR0212522A/pt not_active IP Right Cessation
- 2002-09-13 HU HU0401492A patent/HUP0401492A3/hu unknown
- 2002-09-13 CA CA002460541A patent/CA2460541A1/en not_active Abandoned
- 2002-09-13 EP EP02774468A patent/EP1429763B1/en not_active Expired - Lifetime
- 2002-09-13 JP JP2003530671A patent/JP4554207B2/ja not_active Expired - Fee Related
- 2002-09-13 ES ES02774468T patent/ES2288195T3/es not_active Expired - Lifetime
- 2002-09-13 AT AT02774468T patent/ATE363278T1/de not_active IP Right Cessation
- 2002-09-13 WO PCT/DK2002/000595 patent/WO2003027081A2/en active IP Right Grant
- 2002-09-13 CN CNA028203402A patent/CN1558762A/zh active Pending
-
2004
- 2004-04-13 NO NO20041494A patent/NO20041494L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL369119A1 (en) | 2005-04-18 |
ATE363278T1 (de) | 2007-06-15 |
CA2460541A1 (en) | 2003-04-03 |
JP4554207B2 (ja) | 2010-09-29 |
JP2005508335A (ja) | 2005-03-31 |
CZ2004313A3 (cs) | 2004-07-14 |
HUP0401492A2 (hu) | 2004-11-29 |
US20030229120A1 (en) | 2003-12-11 |
WO2003027081A3 (en) | 2004-03-25 |
EP1429763A2 (en) | 2004-06-23 |
EP1429763B1 (en) | 2007-05-30 |
NO20041494L (no) | 2004-04-13 |
CN1558762A (zh) | 2004-12-29 |
WO2003027081A2 (en) | 2003-04-03 |
MXPA04002404A (es) | 2004-05-31 |
DE60220424T2 (de) | 2008-03-06 |
US7879893B2 (en) | 2011-02-01 |
HUP0401492A3 (en) | 2008-05-28 |
ES2288195T3 (es) | 2008-01-01 |
DE60220424D1 (de) | 2007-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0212522A (pt) | Ligando de ligação de zinco, hexâmero de insulina, preparação aquosa de insulina e métodos de prolongar a ação de uma preparação de insulina e de preparar um ligando de ligação de zinco | |
BRPI0408229A (pt) | preparação farmacêutica, métodos para preparar um ligando de ligação de zinco, para prolongar a ação de uma preparação de insulina estabilizada por ácido e para tratar diabete do tipo 1 ou tipo 2, e, uso de uma preparação | |
TR200000782T2 (tr) | Resorsinol türevleri. | |
AU2003262877A1 (en) | Wireless device operating system (os) application programmer's interface (api) | |
TR200000654T2 (tr) | KAY-Yeni bir bağışıklık sistemi proteini. | |
MXPA03006093A (es) | Derivados de n(fenilsulfonil)glicina y su uso terapeutico. | |
CY1110547T1 (el) | Συμπυκνωμενα πρωτεϊνικα σκευασματα μειωμενου ιξωδους | |
DK160633C (da) | Slangepumpe, isaer til avendelse som insulinpumpe | |
AR025247A1 (es) | Composiciones de granulos de carotenos-xantofilos, estables | |
BR0005321B1 (pt) | bomba peristÁltica e cartucho. | |
WO1999033869A3 (en) | Compounds for immunotherapy and diagnosis of breast cancer and methods for their use | |
MXPA05004993A (es) | Conjugados de hormona del crecimiento humana modificados quimicamente. | |
SV1999000060A (es) | Procedimiento para la preparacion de (s,s)-bencil-2,8-diazabiciclo 4.3.0 nonano ref. 32965-sv | |
BR0009608A (pt) | Compostos para imunoterapia e diagnóstico de câncer de mama e métodos para sua utilização | |
AU2003291972A1 (en) | Pharmaceutical compositions comprising insulin and legends of insulin hexamer | |
MY134966A (en) | Alkaline earth metal complexes and their use | |
ES2185196T3 (es) | Un procedimiento para la preparacion de tetraazamacrociclos. | |
DE59911929D1 (de) | Membrankolbenpumpe | |
EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
WO2001076639A3 (en) | Chemically-modified myelopoietin conjugates | |
MXPA04000068A (es) | Conjugados de progenipoyetina modificados quimicamente. | |
BR0101437A (pt) | Método para preparar um ciclopropeno | |
DE69805002D1 (de) | Kv2.1 antagonisten | |
ID27733A (id) | Metoksiminofenilasetamida | |
BG103779A (en) | Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A, 7A E 8A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2094 DE 22/02/2011. |